Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan A Wilson

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Molecular Imaging and Biology|November 15, 2011
Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PETRobert A Comley, Cristian Salinas, Romina Mizrahi, et al.
Addiction (Abingdon, England)|November 22, 2012
The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]racloprideIsabelle Boileau, Doris Payer, Bindiya Chugani, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 28, 2016
Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesiaJoshua Lister, Ana C Andreazza, Bushra Navaid, et al.
The Lancet. Psychiatry|March 3, 2018
Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional studyElaine Setiawan, Sophia Attwells, Alan A Wilson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 29, 2022
In vivo brain endocannabinoid metabolism is related to hippocampus glutamate and structure - a multimodal imaging study with PET, <sup>1</sup>H-MRS, and MRIJeremy J Watts, Elisa Guma, Sofia Chavez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 2012
Convergent effects of acute stress and glucocorticoid exposure upon MAO-A in humansAlexandra Soliman, Chinelo Udemgba, Ian Fan, et al.
Brain : a Journal of Neurology|January 21, 2009
Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's diseaseIsabelle Boileau, Mark Guttman, Pablo Rusjan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 25, 2016
Association of ventral striatum monoamine oxidase-A binding and functional connectivity in antisocial personality disorder with high impulsivity: A positron emission tomography and functional magnetic resonance imaging studyNathan J Kolla, Katharine Dunlop, Jonathan Downar, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 29, 2008
Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASBIsabelle Boileau, Jerry J Warsh, Mark Guttman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 8, 2002
Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditionsZsolt Szabo, Una D McCann, Alan A Wilson, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Molecular Imaging and Biology|November 15, 2011
Biodistribution and radiation dosimetry of the serotonin 5-HT₆ ligand [¹¹C]GSK215083 determined from human whole-body PETRobert A Comley, Cristian Salinas, Romina Mizrahi, et al.
Addiction (Abingdon, England)|November 22, 2012
The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]racloprideIsabelle Boileau, Doris Payer, Bindiya Chugani, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 28, 2016
Lipoic acid and haloperidol-induced vacuous chewing movements: Implications for prophylactic antioxidant use in tardive dyskinesiaJoshua Lister, Ana C Andreazza, Bushra Navaid, et al.
The Lancet. Psychiatry|March 3, 2018
Association of translocator protein total distribution volume with duration of untreated major depressive disorder: a cross-sectional studyElaine Setiawan, Sophia Attwells, Alan A Wilson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 29, 2022
In vivo brain endocannabinoid metabolism is related to hippocampus glutamate and structure - a multimodal imaging study with PET, <sup>1</sup>H-MRS, and MRIJeremy J Watts, Elisa Guma, Sofia Chavez, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 2012
Convergent effects of acute stress and glucocorticoid exposure upon MAO-A in humansAlexandra Soliman, Chinelo Udemgba, Ian Fan, et al.
Brain : a Journal of Neurology|January 21, 2009
Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's diseaseIsabelle Boileau, Mark Guttman, Pablo Rusjan, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 25, 2016
Association of ventral striatum monoamine oxidase-A binding and functional connectivity in antisocial personality disorder with high impulsivity: A positron emission tomography and functional magnetic resonance imaging studyNathan J Kolla, Katharine Dunlop, Jonathan Downar, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 29, 2008
Elevated serotonin transporter binding in depressed patients with Parkinson's disease: a preliminary PET study with [11C]DASBIsabelle Boileau, Jerry J Warsh, Mark Guttman, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 8, 2002
Comparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditionsZsolt Szabo, Una D McCann, Alan A Wilson, et al.
Pageof 18